Cargando…
NeuroProtect, a Candidate Formula From Traditional Chinese Medicine, Attenuates Amyloid-β and Restores Synaptic Structures in APP/PS1 Transgenic Mice
Background: Alzheimer’s disease (AD) is the most common cause of dementia. The emerging data suggest that cognitive decline occurred in the setting of Aβ accumulation with synaptic dysfunction, which started to happen at preclinical stages. Then, presymptomatic intervention is more critical to postp...
Autores principales: | Tan, Yan, Wang, Xu, Zhang, Jiani, Zhang, Huawei, Li, Haiyan, Peng, Tiantian, Chen, Weihang, Wei, Peng, Liu, Zhaoheng, He, Fang, Li, Jiao, Ding, Haimin, Li, Na, Wang, Zhaoyang, Zhang, Zhenqiang, Hua, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108353/ https://www.ncbi.nlm.nih.gov/pubmed/35586051 http://dx.doi.org/10.3389/fphar.2022.850175 |
Ejemplares similares
-
Exercise-Induced Neuroprotection of Hippocampus in APP/PS1 Transgenic Mice via Upregulation of Mitochondrial 8-Oxoguanine DNA Glycosylase
por: Bo, Hai, et al.
Publicado: (2014) -
Neuropeptide S Ameliorates Cognitive Impairment of APP/PS1 Transgenic Mice by Promoting Synaptic Plasticity and Reducing Aβ Deposition
por: Zhao, Peng, et al.
Publicado: (2019) -
The neuroprotective effects of Liuwei Dihuang medicine in the APP/PS1 mouse model are dependent on the PI3K/Akt signaling pathway
por: Yuan, Ye, et al.
Publicado: (2023) -
Synaptic Changes in the Dentate Gyrus of APP/PS1 Transgenic Mice Revealed by Electron Microscopy
por: Alonso-Nanclares, Lidia, et al.
Publicado: (2013) -
miR-132 regulates the expression of synaptic proteins in APP/PS1 transgenic mice through C1q
por: Xu, Nan, et al.
Publicado: (2019)